Skip to main content
SpringerLink
Log in

Therapie des akuten Herzversagens

  • Conference paper
Refresher Course — Aktuelles Wissen für Anästhesisten

Part of the book series: Refresher Course — Aktuelles Wissen für Anästhesisten ((REFRESHER COUR,volume 19))

  • 20 Accesses

Zusammenfassung

Eine Verbesserung der chirurgischen Technik sowie eine Weiterentwicklung des anästhesiologischen Managements haben zu einer Erweiterung der Operationsindikation auch für früher „inoperable“ Patienten geführt. Die Überalterung der Bevölkerung hat zudem die Zahl der Patienten mit Herzinsuffizienz nicht nur erheblich ansteigen lassen, sie hat auch in 10 Jahren zu einer Verdopplung der hospitalisierten Patienten in diesem Krankengut geführt. Angaben über die Inzidenz der postoperativen Herzinsuffizienz bei nichtherzchirurgischen Eingriffen variieren zwischen 0,2 bis zu 7,0%. Die Letalität dieses Ereignisses liegt dabei erschreckend hoch (zwischen 20 und 40%). Die Therapie der (akuten oder chronischen) kardiozirkulatorischen Insuffizienz stellt somit auch heute noch eine Herausforderung dar.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Baumann G, Felix S (1991) Inodilatoren in der Therapie der kongestiven Myokardinsuffizienz. Bayr Int 12: 32–42

    Google Scholar 

  2. Bendersky R, Chatterje K, Parmley WW, Brundage BH, Ports TA (1981) Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics. Am J Cardiol 48: 554–556

    Article  PubMed  CAS  Google Scholar 

  3. Benotti JR, Grossman W, Braunwald E, Carabello BA (1980) Effects of amrinone on myocardial energy metabolism and hemodynamics in patients with severe congestive heart failure due to coronary artery disease. Circulation 62: 28–34

    PubMed  CAS  Google Scholar 

  4. Bethke T, Eschenhagen T, Klimkiewicz A et al. (1992) Phosphodiesterase inhibition by enoximone in preparations from nonfailing and failing human hearts. Arznmittel-Forsch/Drug Res 41 (I): 437–445

    Google Scholar 

  5. Boldt J, Kling D, Schuhmann E, Dapper F, Hempelmann G (1989) Hämodynamische Effekte des neuen Phosphodiesterasehemmers Enoximone bei kardiochirurgischen Patienten. Anaesthesist 38: 238–244

    PubMed  CAS  Google Scholar 

  6. Boldt J, Kling D, Zickmann B, Dapper F, Hempel-mann G (1990) Haemodynamic effects of the PDEinhibitor enoximone in comparison to dobutamine in esmololtreated cardiac surgery patients. Br J Anaesth 64: 611–616

    Article  PubMed  CAS  Google Scholar 

  7. Böhm M, Gierschik P, Jakobs KH, Schnabel P, Kemkes B, Erdmann E (1989) Localisation of a ‘postreceptor’ defect in human dilated cardiomyopathy. Am J Cardiol 64: 812–814

    Article  PubMed  Google Scholar 

  8. Bristow MR (1984) Myocardial beta-adrenergic receptor down-regulation in heart failure. Int J Cardiol 5: 648–652

    Article  PubMed  CAS  Google Scholar 

  9. Fowler MB, Laser JA, Hopkins GL, Minobe W, Bristow MR (1986) Assessment of the (3-adrenergic receptor pathway in the intact failing human heart: progressive n-receptor down-regulation and specific pharmacologic subsensitivity to agonist response. Circulation 74: 1290–1392

    Article  PubMed  CAS  Google Scholar 

  10. Goenen M, Pedemonte O, Baele P, Col J (1985) Amrinone in the management of low cardiac output after open heart surgery. Am J Cardiol 56: 33B - 38B

    Article  PubMed  CAS  Google Scholar 

  11. Gollub SB, Emmott WW, Johnson DE, Sights KA, Wilson DB, Vacek JL, Hassanein K (1988) Hemodynamic effect of dopexamine hydrochloride infusions of 48 to 72 hours duration for severe congestive heart failure. Am J Cardiol 62: 83C - 88C

    Article  Google Scholar 

  12. Gonzalez M, Desager JP, Jacquemart JL et al. (1988) Efficacy of enoximone in the management of refractory low-output following cardiac surgery. J Cardiothorac Anesth 2: 409–418

    Article  PubMed  CAS  Google Scholar 

  13. Groeneveld ABJ, Schneider AJ, Thijs GJ (1991) Cardiac alterations in septic shock: pathophysiology, diagnosis, prognostic, and therapeutic implications. In: Vincent JL (ed) Update in intensive care and emergency medicine vol 14. Springer, Berlin Heidelberg New York Tokyo, pp 126–136

    Google Scholar 

  14. Herrmann HC, Ruddy TD, Dec GW, Strauss HW, Boucher CA, Fifer MA (1987) Diastolic function in patients with severe heart failure: comparison of the effects of enoximone and nitroprusside. Circulation 75: 1214–122

    Article  PubMed  CAS  Google Scholar 

  15. Hines R (1991) The choice of inotropes following cardiopulmonary bypass. Amrinone is the first-choice inotrope following cardiopulmonary bypass. J Cardiothorac Anesth 5: 181–183

    Article  CAS  Google Scholar 

  16. Insel PA, Ransnäs LA (1988) G-proteins and cardiovascular disease. Circulation 78: 1511–1513

    Article  PubMed  CAS  Google Scholar 

  17. Janicki JS, Shroff SG, Weber KR (1987) Physiologic response to the inotropic and vasodilator properties of enoximone. Am J Cardiol 60: 15C - 118C

    Article  PubMed  CAS  Google Scholar 

  18. Jaski BE, Peters C (1988) Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Am J Cardiol 62: 63C - 67C

    Article  PubMed  CAS  Google Scholar 

  19. Jentzer JH, LeJementel TH, Sonnenblick EH, Kirk ES (1981) Beneficial effects of amrinone on myocardial oxygen consumption during acute left ventricular failure in dogs. Am J Cardiol 48: 75–83

    Article  PubMed  CAS  Google Scholar 

  20. Kox WJ, Brydon C (1991) Improvement of tissue oxygenation with enoximone in septic shock. In: Vincent JL (ed) Update in intensive care and emergency medicine vol 14. Springer, Berlin Heidelberg New York Tokyo, pp 137–143

    Google Scholar 

  21. Kramer W, Waas W, Tillmanns H (1991) Therapie der chronischen Herzinsuffizienz. Arzneimitteltherapie 9: 102–110

    Google Scholar 

  22. Löllgen H (1991) Katecholamine in der Therapie der akuten Herzinsuffizienz — Effektivität und Grenzen. Intensivmedizin 21 [Supp]11: 21–32

    Google Scholar 

  23. Manz J, Marty J, Pansard Y, Henzel D, Loiseau A, Pocidalo M, Langlois J, Desmonts JM (1990) Betaadrenergic receptor changes during coronary artery bypass grafting. J Thorac Cardiovasc Surg 99: 75–81

    Google Scholar 

  24. Monrad ES, Bairn DS, Smith HS (1986) Milrinone, dobutamine and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 73 [Suppl III]: 168

    Google Scholar 

  25. Renard M, Dereppe H, Henuzeit C, Stevens E, Bernard B (1988) Effects of enoximone in patients with cardiac failure after myocardial infarction. BJCP 12 [Supp] 651: 37–40

    Google Scholar 

  26. Rettig GF, Bette L (1988) Current therapy of acute heart failure. Cardiovasc Drugs Therapy 2: 401–406

    Article  Google Scholar 

  27. Rutman HI, LeJemtel TH, Sonnenblick EH (1987) Newer cardiotonic agents: implications for patients with heart failure and ischemic heart disease. J Cardiovasc Anesth 1: 59–70

    Article  CAS  Google Scholar 

  28. Scholz H (1984) Inotropic drugs and their mechanism of action. JACC 4: 389–397

    PubMed  CAS  Google Scholar 

  29. Rettig GF, Bette L (1988) Current therapy of acute heart failure. Cardiovasc Drugs Therapy 2: 401–406

    Article  Google Scholar 

  30. Skoyles JR, Sherry KM (1992) Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors. Br J Anaesth 68: 293–302

    Article  PubMed  CAS  Google Scholar 

  31. Unverfert DV, Blaunford M, Kates RE, Leier CV (1980) Tolerance to dobutamine after a 72-hour continuous infusion. Am J Med 69: 262–266

    Article  Google Scholar 

  32. Vincent JL, Carlier E, Bene J, Armistead CW, Kahn R, Coussaert E, Cantraine F (1988) Administration of enoximone in cardiogenic shock. Am J Cardiol 62: 419–423

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. J. Boldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Hammermann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Hempelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Boldt, J., Hammermann, H., Hempelmann, G. (1993). Therapie des akuten Herzversagens. In: Refresher Course — Aktuelles Wissen für Anästhesisten. Refresher Course — Aktuelles Wissen für Anästhesisten, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78493-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-78493-4_13

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-57197-1

  • Online ISBN: 978-3-642-78493-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation